Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults
Clinical trial NCT00413725 · COMPLETED
Trial details
- NCT number
- NCT00413725
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2012-08-01
- Enrollment
- 801
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.